Hi all,
we had a good productive meeting and made a plan to move forward on
RxNorm. Here are the minutes :
http://www.w3.org/2013/03/06-HCLS-minutes.html
m.
On Tue, Mar 5, 2013 at 1:31 PM, w3.h...@gmail.com wrote:
> Tomorrow's clinical pharmacogenomics call will center around RxNorm. Janos
>
There is crucial negation missing from my earlier post. Apologies.
In practice, creating an RDF version the the content in 1) above would
*NOT* violate the UMLS license agreement, as long as NLM is acknowledged
as the provider of the data.
-
Quick clarification.
RxNorm is several things
Olivier,
In practice, creating an RDF version the the content in 1) above would
> violate the UMLS license agreement, as long as NLM is acknowledged as the
> provider of the data.
you meant would *not* violate the UMLS agreement, right?
m.
--
Michel Dumontier
Associate Professor of Bioinforma
Quick clarification.
RxNorm is several things in one box.
1) Everything tagged with the provenance SAB=RXNORM belongs to NLM and
is publicly available. This includes at least one normalized name and
code ("RxCUI") for each drug entity in scope. It also includes the
majority on NDCs.
2) Content
Will there be anybody discussing the license issues, which seem to disallow
this kind of dissemination?
-Alan
On Tue, Mar 5, 2013 at 1:31 PM, w3.h...@gmail.com wrote:
> Tomorrow's clinical pharmacogenomics call will center around RxNorm. Janos
> Hajagos will discuss his approach to converting R
